News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phenomix Corporation Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors



10/17/2007 11:03:22 AM

SAN DIEGO--(BUSINESS WIRE)--Phenomix Corporation, a drug discovery and development company with lead programs in diabetes and hepatitis C, announced today John Crawford was named chief financial officer, and Arlene M. Morris was appointed to the company’s Board of Directors. In his 25 years of experience, Crawford has served as a corporate officer or director for several companies, guiding them through listings on NASDAQ as well as facilitating acquisitions. Morris has more than 25 years of management experience in the health care industry, most recently as president and chief executive officer of Affymax Inc.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES